Vitamin D Supplementation and Testosterone Levels in Breast Cancer Survivors
Vitamin D Supplementation and Testosterone Levels in Breast Cancer Survivors
Minopoli et al., 2025 | Int J Mol Sci | Rct
Citation
Minopoli Anita, Di Gennaro Piergiacomo, ... Augustin Livia S A. Vitamin D Supplementation and Testosterone Levels in Breast Cancer Survivors. Int J Mol Sci. 2025-Oct-15;26(20). doi:10.3390/ijms262010030
Abstract
Vitamin D plays a key role in immune modulation, cell proliferation, and hormone regulation. Dysregulated testosterone may contribute to breast cancer progression. We investigated whether long-term vitamin D supplementation affects serum testosterone levels in breast cancer survivors. Complete data at baseline, 12, and 24 months were derived from 253 women with early-stage breast cancer participating in the DEDiCa trial and randomized to receive either a high-dose vitamin D to maintain serum 25(OH)D at 60 ng/mL (group A) or a standard dose to maintain serum levels at 30 ng/mL (group B). Serum 25(OH)D levels significantly increased in both groups (p < 0.001). No significant changes in testosterone concentrations were observed between treatment groups over the 24 month treatment period (A: 0.125 to 0.140 ng/mL; B: 0.162 to 0.193 ng/mL; p = 0.682). Baseline serum testosterone levels emerged as the most significant predictor of testosterone trajectories, possibly modulated by hormone-suppressive therapy. These results are reassuring that vitamin D supplementation did not adversely affect testosterone levels in this population of breast cancer survivors and may partially concur with a healthy lifestyle to equilibrate testosterone levels.
Key Findings
These results are reassuring that vitamin D supplementation did not adversely affect testosterone levels in this population of breast cancer survivors and may partially concur with a healthy lifestyle to equilibrate testosterone levels.
Outcomes Measured
- Requires manual extraction
Population
| Field | Value |
|---|---|
| Population | See abstract |
| Sample Size | See abstract |
| Age Range | See abstract |
| Condition | See abstract |
MeSH Terms
- Humans
- Breast Neoplasms
- Female
- Testosterone
- Vitamin D
- Cancer Survivors
- Middle Aged
- Dietary Supplements
- Aged
- Adult
Evidence Classification
- Level: Rct
- Publication Types: Journal Article, Randomized Controlled Trial
- Vertical: vitamin-d-cancer
Provenance
- PMID: 41155322
- DOI: 10.3390/ijms262010030
- PMCID: PMC12564732
- Verified: 2026-04-09 via PubMed E-utilities API
Source extracted via PubMed E-utilities API on 2026-04-09